share_log

Regeneron Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer

SEC ·  Aug 10, 2023 05:15
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.